BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
JTT-705, soluble in DMSO and ethanol and insoluble in water, is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting CETP. The molecular weight of the compound is 389.6, and its molecular formula is C23H35NO2S. It targets the rhCETP.
Molecular Weight
389.6
Molecular Formula
C23H35NO2S
Targets
rhCETP
Form
Lyophilized powder
Purity
≥98%
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Solubility
In vitro: DMSO: 66 mg/mL (169.41 mM); Water: insoluble; Ethanol: 66 mg/mL (169.41 mM); In vivo: 0.5% methylcellulose, 28 mg/mL
Identity
Confirmed by NMR/HPLC/MS.
Applications
JTT-705 plays a key role in helping increase HDL cholesterol levels and decrease LDL cholesterol levels, which may be beneficial in managing hyperlipidemia and reducing cardiovascular risk.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.